Skip to content

Weight-loss application: short-term study of efficacy in the setting of supervised weight-loss activities

Prospective, randomized study of short-term weight loss outcomes using gamification-based strategy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN30309753
Enrollment
100
Registered
2019-07-19
Start date
2017-01-16
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Nutritional, Metabolic, Endocrine Obesity

Interventions

A total of 100 patients from one of the SLUHN Bariatric Clinics with an available medically supervised weight-loss program were allocated to intervention or control using alternate allocation.
those using Ayogo app (intervention group) and those who do not (control group). The app includes motivational tools, informative content, food/activity/weight tracking (which is known to support weig

Sponsors

St. Luke's University Health Network (SLUHN)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >18 years 2. Owns or has access to a smartphone 3. Proficient in English 4. Comfortable using the app 5. Attending a weight-loss programme at one of the SLUHN bariatric clinics

Exclusion criteria

Exclusion criteria: Do not meet the inclusion criteria

Design outcomes

Primary

MeasureTime frame
1. Weight measured weekly from baseline to 3-months 2. Degree of individual interaction with app and app usage measured over the course of the program using: 2.1 Encouragements received 2.2 Encouragements received in first two weeks 2.3 Total number of swipes 2.4 Total active days on app 2.5 Social wall likes 2.6 Social wall answers 2.7 Daily Quest answers 2.8 Narratives page views 2.9 Number of weight, exercise, and diet entries 3. Patient engagement using a secondary Patient Engagement Questionnaire administered on monthly basis

Secondary

MeasureTime frame
1. Glucose control measured by Hemoglobin A1c at baseline and 3-months 2. Number of emergency and physician office visits over the 3-month period

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026